These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 7949173)

  • 1. Serum levels of soluble intercellular adhesion molecule 1 are increased in chronic B-lymphocytic leukemia and correlate with clinical stage and prognostic markers.
    Christiansen I; Gidlöf C; Wallgren AC; Simonsson B; Tötterman TH
    Blood; 1994 Nov; 84(9):3010-6. PubMed ID: 7949173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum levels of soluble vascular cell adhesion molecule-1 (sVCAM-1) closely reflect tumour burden in chronic B-lymphocytic leukaemia.
    Christiansen I; Sundström C; Tötterman TH
    Br J Haematol; 1998 Dec; 103(4):1129-37. PubMed ID: 9886331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
    Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
    Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble ICAM-1 in Hodgkin's disease: a promising independent predictive marker for survival.
    Christiansen I; Enblad G; Kälkner KM; Gidlöf C; Glimelius B; Tötterman TH
    Leuk Lymphoma; 1995 Oct; 19(3-4):243-51. PubMed ID: 8535215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of sIL2R, sCD23, sICAM-1, IL6 and sCD 14 serum levels in B-cell chronic lymphocytic leukemia.
    Callea V; Morabito F; Luise F; Piromalli A; Filangeri M; Stelitano C; Iacopino P; Nobile F; Brugiatelli M
    Haematologica; 1996; 81(4):310-5. PubMed ID: 8870374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
    Reinisch W; Willheim M; Hilgarth M; Gasché C; Mader R; Szepfalusi S; Steger G; Berger R; Lechner K; Boltz-Nitulescu G
    J Clin Oncol; 1994 Oct; 12(10):2146-52. PubMed ID: 7931486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression.
    Molica S; Vitelli G; Levato D; Giannarelli D; Gandolfo GM
    Cancer; 2001 Aug; 92(4):713-9. PubMed ID: 11550139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of tetranectin, intercellular adhesion molecule-1 and interleukin-10 in B-chronic lymphocytic leukemia.
    Kamper EF; Papaphilis AD; Angelopoulou MK; Kopeikina LT; Siakantaris MP; Pangalis GA; Stavridis JC
    Clin Biochem; 1999 Nov; 32(8):639-45. PubMed ID: 10638947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated serum levels of soluble ICAM-1 in non-Hodgkin's lymphomas correlate with tumour burden, disease activity and other prognostic markers.
    Christiansen I; Gidlof C; Kälkner K M; Hagberg H; Bennmarker H; Tötterman T
    Br J Haematol; 1996 Mar; 92(3):639-46. PubMed ID: 8616029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia.
    Sarfati M; Chevret S; Chastang C; Biron G; Stryckmans P; Delespesse G; Binet JL; Merle-Beral H; Bron D
    Blood; 1996 Dec; 88(11):4259-64. PubMed ID: 8943862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia.
    Hallek M; Langenmayer I; Nerl C; Knauf W; Dietzfelbinger H; Adorf D; Ostwald M; Busch R; Kuhn-Hallek I; Thiel E; Emmerich B
    Blood; 1999 Mar; 93(5):1732-7. PubMed ID: 10029603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-2 receptor, soluble CD8 and soluble intercellular adhesion molecule-1 levels in hematologic malignancies.
    Srivastava MD; Srivastava A; Srivastava BI
    Leuk Lymphoma; 1994 Jan; 12(3-4):241-51. PubMed ID: 7909467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: implications for prognosis.
    Molica S; Dattilo A; Mannella A; Levato D; Levato L
    Leuk Res; 1995 Aug; 19(8):573-80. PubMed ID: 7658704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.
    Molica S; Levato D; Dell' Olio M; Cascavilla N; Matera R; Minervini M; Dattilo A; Carotenuto M; Musto P
    Haematologica; 1997; 82(2):148-51. PubMed ID: 9175316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic significance of lactate dehydrogenase and beta2-microglobulin in chronic lymphocytic leukemia].
    Shen QD; Xu W; Yu H; Li L; Zhang SJ; Li JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Dec; 15(6):1305-8. PubMed ID: 18088490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic lymphocytic leukemia and prognostic factors.
    Mozaheb Z; Hasanzadeh NazarAbadi MH; Aghaee MA
    Asian Pac J Cancer Prev; 2012; 13(7):3009-13. PubMed ID: 22994703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating levels of intercellular adhesion molecule-1 (ICAM-1) and soluble interleukin 2 receptors (IL-2R) in patients with B cell chronic lymphocytic leukaemia.
    Musolino C; Alonci A; Allegra A; Bellomo G; Spatari G; Pernice F; Squadrito G; Quartarone C; Tringali O; Quartarone M
    Riv Eur Sci Med Farmacol; 1996; 18(3):113-8. PubMed ID: 9177607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of syndecan-1 in B-cell chronic lymphocytic leukemia: correlation with the extent of angiogenesis and disease-progression risk in early disease.
    Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
    Leuk Lymphoma; 2006 Jun; 47(6):1034-40. PubMed ID: 16840194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A distinct profile of serum levels of soluble intercellular adhesion molecule-1 and intercellular adhesion molecule-3 in mycosis fungoides and Sézary syndrome.
    López-Lerma I; Estrach MT
    J Am Acad Dermatol; 2009 Aug; 61(2):263-70. PubMed ID: 19615537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.